Clinical trial
Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer, a Multicenter Prospective Randomized Study to Evaluate the Use of Local Therapy
NCT01015625 is registered in ClinicalTrials.gov with Austrian Breast & Colorectal Cancer Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer, a Multicenter Prospective Randomized Study to Evaluate the Use of Local Therapy
- Lead sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 24, 2010
- Completion date
- July 31, 2022
- Enrollment
- 90 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
circulating tumor cells, synchronous metastasized breast cancer